ABCG2 and hepatocellular carcinoma: FZD7 as an FZD receptor, ABC transporters (ABCB1, ABCC1, and ABCC2) can be upregulated in HCC cells by FZD7 overexpression via this pathway which results in increased therapy resistance in HCC.